Atlas Trials

A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease

Clinical trial NCT00229736 · COMPLETED

Trial details

NCT number
NCT00229736
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2004-11-01
Primary completion
2013-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.